Trial intelligence / Profile preview

PSD502 for pain control during outpatient hysteroscopy

ISRCTN46090514Phase 2Completed

Sponsor
Plethora Solutions
Start
Jan 2008
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, double-blind trial comparing PSD502 with Placebo (2 arms). Primary endpoint: Pain at tenaculum placement. Started Jan 2008; status: completed.

02

Drugs

lidocaine + prilocaine

Beyond the preview

Go deeper on ISRCTN46090514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN46090514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call